# OnCo record nct06998108 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06998108/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06998108", "NCT06998108" ;
  schema:name "Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy"@en ;
  schema:description "A phase 3 trial testing BEBT-209 in HR-positive / HER2-negative breast cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06998108/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06998108> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2022-06-09" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/bebt-209/> ;
  onco:companies <https://onco.cc/companies/bebetter-med/> .